Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. (NLTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NLTX · as of Jun 8, 2026
Key Statistics
Explore Neoleukin Therapeutics, Inc. Data
nltx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 35.7%
Competitors & Peers
nltx competitorsNLTX
BIOR
CHRO
CNTG
CSCI
DMKPQStock Performance
Full HistoryAbout Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, util…
what is neoleukin therapeutics, inc. · nltx stock overview · neoleukin therapeutics, inc. company profile · who is neoleukin therapeutics, inc. ceo · nltx NASDAQ · neoleukin therapeutics, inc. headquarters · neoleukin therapeutics, inc. business segments
About Stock Overview & Key Data
Neoleukin Therapeutics, Inc. (NLTX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Mar 7, 2014. As of the latest trading session, NLTX stock price is $3.49, with a market capitalization of $8.2M. The stock has returned -69.39% over the past 12 months and +0.00% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Neoleukin Therapeutics, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Neoleukin Therapeutics, Inc. reported revenue of — and net income of -$90.4M. For detailed data — including Neoleukin Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Neoleukin Therapeutics, Inc. (NLTX) stock price is $3.49. The stock is traded on NASDAQ under the ticker symbol NLTX. The 52-week range is $3.42 – $18.80.